Wellvana Welcomes Dr. David Rankey as New Chief Medical Officer to Enhance Clinical Leadership
Wellvana Welcomes Dr. David Rankey as Chief Medical Officer
In a strategic move to strengthen its clinical leadership, Wellvana has announced the appointment of Dr. David Rankey as its new Chief Medical Officer. This decision is significant as Wellvana continues to establish itself as a national leader in value-based care enablement. Dr. Rankey's impressive background in healthcare will enhance the organization's commitment to delivering better patient outcomes.
Dr. Rankey joins Wellvana with a wealth of experience, having served as the National Chief Medical Officer of Clinical Excellence at Optum Health. In that role, he oversaw a massive affordability portfolio worth $700 million, serving over five million patients across 12 states. This experience is expected to bring valuable insights into navigating the complexities of value-based care as Wellvana aims to deepen its partnerships within the healthcare ecosystem.
Susan Diamond, CEO of Wellvana, expressed enthusiasm about Dr. Rankey's appointment, emphasizing his proven track record in clinical care and his capacity to foster meaningful relationships with healthcare providers. “David has been in the exam room, run scaled care programs with demonstrated impact, and built the kind of trust with providers that actually moves behavior,” Diamond stated. This highlights the fundamental need for organizational leaders who can connect effectively with clinicians and drive change in patient care.
Under Dr. Rankey’s leadership at Optum Health and previously at Kaiser Permanente Washington, he played a pivotal role in implementing clinical strategies that yielded impressive results. Notably, hospital admissions were reduced by as much as 20%, and he led programs that achieved $100 million in annual savings at Kaiser Permanente. His background as an emergency medicine practitioner across various Level 1 and Level 2 trauma centers also provides him with firsthand insights into the challenges faced in modern healthcare.
“Value-based care is at an inflection point,” Dr. Rankey remarked. He believes that the future models of care must do more than just show potential savings on paper; they must also foster a sense of belonging among providers. “The models that are going to succeed aren’t just those that save money. They’re where providers feel they're part of a movement that truly connects their daily efforts with better outcomes for patients,” he stated. This perspective aligns seamlessly with Wellvana's mission, making his transition to the company a natural fit.
As the healthcare landscape evolves, Wellvana is positioning itself advantageously. The company has generated an impressive $337 million in gross savings via its MSSP (Medicare Shared Savings Program) and has been recognized as one of the top-performing ACOs in the nation based on this metric. With Dr. Rankey on board, the organization anticipates further advancements in its clinical methodologies and initiatives aimed at improving care delivery.
Dr. Rankey received his MD from the University of Cincinnati College of Medicine and holds a Master of Public Health from the University of Michigan. He is based in Denver, Colorado, and will soon be engaging with peers and industry leaders at the upcoming Accountable Care Symposium from May 12-14. There, he will lead a roundtable discussion spotlighting the winners of Wellvana's inaugural CARE Awards – an event aimed at recognizing excellence in accountable care.
In conclusion, Dr. David Rankey's appointment is a significant step forward for Wellvana as it seeks to not only enhance its clinical leadership but also redefine how healthcare can successfully navigate the shift towards value-based care. With an adept leader at the helm, Wellvana is poised to further its mission of enabling better patient outcomes and optimizing healthcare delivery across its expansive network.